The DCGI has said the approval is in “clinical trial mode†but has not clarified this in detail. If an experimental vaccine is given to people, there should be informed consent explaining the potential risks and benefits of the vaccine and post-vaccination follow-up. In case there is any serious adverse reaction, the recipient may also be eligible for compensation.Explained: Why conditional approval for Bharat Biotech’s Covaxin is raising questions
The DCGI has said the approval is in “clinical trial mode†but has not clarified this in detail. If an experimental vaccine is given to people, there should be informed consent explaining the potential risks and benefits of the vaccine and post-vaccination follow-up. In case there is any serious adverse reaction, the recipient may also be eligible for compensation.
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
No comments:
Post a Comment